A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects

Summary

This study was a randomized, double-blind, placebo-controlled phase I clinical trial of TQH3821 in adult healthy subjects, which plans to recruit 72 healthy subjects. The main purpose was to evaluate the safety and tolerance of different doses of TQH3821 or in combination with methotrexate tablets after single and multiple administration in healthy subjects.

Timeline

Start

2022-05-29

Primary completion

2023-05-20

Completion

2023-05-20

Drugs

Indications